Hereditary spastic paraplegia: Novel insights into the pathogenesis and management

Hereditary spastic paraplegia is a genetically heterogeneous neurodegenerative disorder characterised primarily by muscle stiffness in the lower limbs. Neurodegenerative disorders are conditions that result from cellular and metabolic abnormalities, many of which have strong genetic ties. While agei...

Full description

Saved in:

Bibliographic Details
Published in:	SAGE open medicine Vol. 12; p. 20503121231221941
Main Authors:	Awuah, Wireko Andrew, Tan, Joecelyn Kirani, Shkodina, Anastasiia D, Ferreira, Tomas, Adebusoye, Favour Tope, Mazzoleni, Adele, Wellington, Jack, David, Lian, Chilcott, Ellie, Huang, Helen, Abdul-Rahman, Toufik, Shet, Vallabh, Atallah, Oday, Kalmanovich, Jacob, Jiffry, Riaz, Madhu, Divine Elizabeth, Sikora, Kateryna, Kmyta, Oleksii, Delva, Mykhailo Yu
Format:	Journal Article
Language:	English
Published:	England SAGE Publications 01-01-2024 SAGE Publishing
Subjects:	Review neurodegeneration metabolism genetics Hereditary spastic hyperplasia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Hereditary spastic paraplegia is a genetically heterogeneous neurodegenerative disorder characterised primarily by muscle stiffness in the lower limbs. Neurodegenerative disorders are conditions that result from cellular and metabolic abnormalities, many of which have strong genetic ties. While ageing is a known contributor to these changes, certain neurodegenerative disorders can manifest early in life, progressively affecting a person's quality of life. Hereditary spastic paraplegia is one such condition that can appear in individuals of any age. In hereditary spastic paraplegia, a distinctive feature is the degeneration of long nerve fibres in the corticospinal tract of the lower limbs. This degeneration is linked to various cellular and metabolic processes, including mitochondrial dysfunction, remodelling of the endoplasmic reticulum membrane, autophagy, abnormal myelination processes and alterations in lipid metabolism. Additionally, hereditary spastic paraplegia affects processes like endosome membrane trafficking, oxidative stress and mitochondrial DNA polymorphisms. Disease-causing genetic loci and associated genes influence the progression and severity of hereditary spastic paraplegia, potentially affecting various cellular and metabolic functions. Although hereditary spastic paraplegia does not reduce a person's lifespan, it significantly impairs their quality of life as they age, particularly with more severe symptoms. Regrettably, there are currently no treatments available to halt or reverse the pathological progression of hereditary spastic paraplegia. This review aims to explore the metabolic mechanisms underlying the pathophysiology of hereditary spastic paraplegia, emphasising the interactions of various genes identified in recent network studies. By comprehending these associations, targeted molecular therapies that address these biochemical processes can be developed to enhance treatment strategies for hereditary spastic paraplegia and guide clinical practice effectively.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	2050-3121 2050-3121
DOI:	10.1177/20503121231221941